Dame June Raine, Chief Executive of the Medicines and Healthcare products Regulatory Agency (MHRA), has today announced that she will be stepping down in the Autumn following five years in the role. She took up the post in August 2019, following a career in medicines regulation.
The Department of Health and Social Care (DHSC) will shortly begin recruitment for a new Chief Executive. Dame June will remain in post until the Autumn to ensure a smooth transition to her successor.
Dame June said: ‘It has been an enormous privilege to have led the MHRA through a time of change which is unprecedented in UK medical products regulation.
‘I am especially proud that during the last 5 years the Agency has built a new vigilance system, strengthened international and national partnerships, and delivered regulation which has enabled groundbreaking innovation, from gene therapy for sickle cell disease and the world’s first Covid vaccine, to being close to eradicating polio, and from medical device software to AI diagnostics.’
BIVDA wish her the very best with the next stage in her career and watch with interest to see who will take over this key position.
